Fact CheckerSign in

NCT04259632Completed

Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans

Source: ClinicalTrials.gov · Last updated 23 Jan 2026

Brief summary (registry, in English)

Purpose: Obesity is reaching epidemic proportions, affecting 36% of the adult population in the United States. There is intense interest in dietary management to treat obesity and its associated complications. The first line of obesity treatment is caloric restriction (CR), although recidivism is common. For moderate CR, attrition rates of 20% are often reported, therefore weight loss options beyond CR are urgently needed.

Status (registry)
Completed
Study type
Interventional
Enrollment
115 (actual)
First submitted
4 Feb 2020
Start date
15 Oct 2020
Primary completion date
12 Oct 2023
Lead sponsor
University of Minnesota
Diseases
Obesity
NCT number
NCT04259632

What you commit to

  • Study type: Interventional
  • Participants enrolled: 115
  • From 15 Oct 2020 to the primary completion date, 12 Oct 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of beta-blockers or medications known to affect weight, such as thiazolidinedione (TZD), insulin, glucagon-like peptide (GLP)-1 agonists, phentermine, or sibutamine

Other illness

  • Clinically significant medical issues (diabetes, cardiovascular disease, uncontrolled pulmonary disease)
  • Concern for active eating disorder per screening questionnaire
  • Self-reported eating disorder or history of eating disorder

Lab values

  • A history of abnormal laboratory results, such as hematologic (platelets \< 100), hepatic (LFTs \> 2X nl), renal (Cr \> 1.5)

Other

  • Shift work (i.e. working from 11pm to 7am)
  • MRI contraindication (metal in body, claustrophobia)
  • Eating window \< 12 hours per day
  • Unable to consistently document food intake using the mCC app (need at least 2 eating occasions\> 6 hours apart on a given day for at least 50% of days)
  • Pregnancy
  • Illiteracy

Who the study is looking for

  • BMI ≥30 and ≤ 55 kg/m\^2
  • Own a smartphone compatible with the myCircadianClock (mCC) phone application
  • Self-reported habitual wakening between 5-9 am
  • Self reported sleep duration of 6-9 hours
  • Weight must be stable \[+/- 5 pounds\] for at least 3 months prior to the study
  • Eating window (time between 1st food intake and last food take) ≥14 hours using mCC
  • Insulin resistance based on HOMA-IR≥ 2.5 from screening visit results
  • Able to understand English

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Minnesota
Coordinator of this site? Confirm its status
MinneapolisUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.